Immune response in cancer patients treated with adjuvant immunochemotherapy

M. Fukushima, A. Gochi, H. Koie, K. Orita

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In order to evaluate the immune response in cancer patients treated with adjuvant immunochemotherapy, a committee was organized in Japanese research Society for Surgical Cancer Immunology. Skin reactions, subsets of PBL, HLA, immunosuppressor (IAP), Immunoactivity (NK activity and lymphoblastogenesis with PHA), general nutritional condition and performance status were picked up and discussed as to how these reactions influence the prognosis of patients. For example, 395 cases of gastric cancer (excluded stage I, non-chemotherapy and absolute non-curative resection) collected from the committee's hospital were divided into two groups, according to a statistical "cut off point", i.e., more than 5.9g/dl of TP, 4.0g/dl of Alb, and 1500/mm3 of PBL, and values less than these. The five-year survival rate was significantly high in the former group. In the group that kept high counts of these parameters after operation, the 5-year survival rate was significantly high in cases which received immunotherapy. In conclusion, immunoparameters paralleled to the stage of disease and prognosis. When the parameters remained at high levels after operation, the immunotherapy group showed good survival compared to the non-immunotherapy group. Immunotherapy is not valuable in patients with high IAP levels and poor nutritional condition.

Original languageEnglish
Pages (from-to)1241-1245
Number of pages5
JournalNippon Geka Gakkai zasshi
Volume92
Issue number9
Publication statusPublished - Sep 1991
Externally publishedYes

Fingerprint

Immunotherapy
Survival Rate
Neoplasms
Allergy and Immunology
Stomach Neoplasms
Skin
Survival
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fukushima, M., Gochi, A., Koie, H., & Orita, K. (1991). Immune response in cancer patients treated with adjuvant immunochemotherapy. Nippon Geka Gakkai zasshi, 92(9), 1241-1245.

Immune response in cancer patients treated with adjuvant immunochemotherapy. / Fukushima, M.; Gochi, A.; Koie, H.; Orita, K.

In: Nippon Geka Gakkai zasshi, Vol. 92, No. 9, 09.1991, p. 1241-1245.

Research output: Contribution to journalArticle

Fukushima, M, Gochi, A, Koie, H & Orita, K 1991, 'Immune response in cancer patients treated with adjuvant immunochemotherapy', Nippon Geka Gakkai zasshi, vol. 92, no. 9, pp. 1241-1245.
Fukushima M, Gochi A, Koie H, Orita K. Immune response in cancer patients treated with adjuvant immunochemotherapy. Nippon Geka Gakkai zasshi. 1991 Sep;92(9):1241-1245.
Fukushima, M. ; Gochi, A. ; Koie, H. ; Orita, K. / Immune response in cancer patients treated with adjuvant immunochemotherapy. In: Nippon Geka Gakkai zasshi. 1991 ; Vol. 92, No. 9. pp. 1241-1245.
@article{a92d1957ecd04cb9919a05f757a4f980,
title = "Immune response in cancer patients treated with adjuvant immunochemotherapy",
abstract = "In order to evaluate the immune response in cancer patients treated with adjuvant immunochemotherapy, a committee was organized in Japanese research Society for Surgical Cancer Immunology. Skin reactions, subsets of PBL, HLA, immunosuppressor (IAP), Immunoactivity (NK activity and lymphoblastogenesis with PHA), general nutritional condition and performance status were picked up and discussed as to how these reactions influence the prognosis of patients. For example, 395 cases of gastric cancer (excluded stage I, non-chemotherapy and absolute non-curative resection) collected from the committee's hospital were divided into two groups, according to a statistical {"}cut off point{"}, i.e., more than 5.9g/dl of TP, 4.0g/dl of Alb, and 1500/mm3 of PBL, and values less than these. The five-year survival rate was significantly high in the former group. In the group that kept high counts of these parameters after operation, the 5-year survival rate was significantly high in cases which received immunotherapy. In conclusion, immunoparameters paralleled to the stage of disease and prognosis. When the parameters remained at high levels after operation, the immunotherapy group showed good survival compared to the non-immunotherapy group. Immunotherapy is not valuable in patients with high IAP levels and poor nutritional condition.",
author = "M. Fukushima and A. Gochi and H. Koie and K. Orita",
year = "1991",
month = "9",
language = "English",
volume = "92",
pages = "1241--1245",
journal = "Nihon Geka Gakkai zasshi",
issn = "0301-4894",
publisher = "Nihon Geka Gakkai",
number = "9",

}

TY - JOUR

T1 - Immune response in cancer patients treated with adjuvant immunochemotherapy

AU - Fukushima, M.

AU - Gochi, A.

AU - Koie, H.

AU - Orita, K.

PY - 1991/9

Y1 - 1991/9

N2 - In order to evaluate the immune response in cancer patients treated with adjuvant immunochemotherapy, a committee was organized in Japanese research Society for Surgical Cancer Immunology. Skin reactions, subsets of PBL, HLA, immunosuppressor (IAP), Immunoactivity (NK activity and lymphoblastogenesis with PHA), general nutritional condition and performance status were picked up and discussed as to how these reactions influence the prognosis of patients. For example, 395 cases of gastric cancer (excluded stage I, non-chemotherapy and absolute non-curative resection) collected from the committee's hospital were divided into two groups, according to a statistical "cut off point", i.e., more than 5.9g/dl of TP, 4.0g/dl of Alb, and 1500/mm3 of PBL, and values less than these. The five-year survival rate was significantly high in the former group. In the group that kept high counts of these parameters after operation, the 5-year survival rate was significantly high in cases which received immunotherapy. In conclusion, immunoparameters paralleled to the stage of disease and prognosis. When the parameters remained at high levels after operation, the immunotherapy group showed good survival compared to the non-immunotherapy group. Immunotherapy is not valuable in patients with high IAP levels and poor nutritional condition.

AB - In order to evaluate the immune response in cancer patients treated with adjuvant immunochemotherapy, a committee was organized in Japanese research Society for Surgical Cancer Immunology. Skin reactions, subsets of PBL, HLA, immunosuppressor (IAP), Immunoactivity (NK activity and lymphoblastogenesis with PHA), general nutritional condition and performance status were picked up and discussed as to how these reactions influence the prognosis of patients. For example, 395 cases of gastric cancer (excluded stage I, non-chemotherapy and absolute non-curative resection) collected from the committee's hospital were divided into two groups, according to a statistical "cut off point", i.e., more than 5.9g/dl of TP, 4.0g/dl of Alb, and 1500/mm3 of PBL, and values less than these. The five-year survival rate was significantly high in the former group. In the group that kept high counts of these parameters after operation, the 5-year survival rate was significantly high in cases which received immunotherapy. In conclusion, immunoparameters paralleled to the stage of disease and prognosis. When the parameters remained at high levels after operation, the immunotherapy group showed good survival compared to the non-immunotherapy group. Immunotherapy is not valuable in patients with high IAP levels and poor nutritional condition.

UR - http://www.scopus.com/inward/record.url?scp=0026230091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026230091&partnerID=8YFLogxK

M3 - Article

C2 - 1944196

AN - SCOPUS:0026230091

VL - 92

SP - 1241

EP - 1245

JO - Nihon Geka Gakkai zasshi

JF - Nihon Geka Gakkai zasshi

SN - 0301-4894

IS - 9

ER -